The shareholders of
Right to attend the Meeting
Shareholders who wish to attend the meeting, must
- be registered the share register maintained by
Euroclear Sweden AB as of Monday17 April 2023 . -
also to register with
Bioservo by mail toBioservo AB (publ), Torshamnsgatan 35, 164 40 Kista or by e-mail to invest@bioservo.com, latest on Wednesday19 April 2023 . Notification shall include the shareholders name, personal identification number/corporate registration number, shareholding, address, telephone number, as well as, wherever applicable, details of representatives, proxies, and advisors.
Nominee-registered shares
For shareholders who have their shares registered through a bank or other nominee, the following applies in order to be entitled to participate in the meeting. In addition to giving notice of participation such shareholder must re-register its shares in its own name so that the shareholder is registered in the share register kept by
Proxy
Shareholders represented by proxy must submit a dated power of attorney. If the power of attorney is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The power of attorney may not be valid for a longer period than five years from its issuance. A copy of the power of attorney and certification should be submitted to the Company by post at the address mentioned above in duly time prior to the Meeting. Power of attorney in original and registration certificate must also be presented at the AGM. The form for power of attorney will be available via the Company's website, www.bioservo.com, and sent free of charge to the shareholders who request it and state their postal address.
Annual report
The annual report and the auditor's report will be available on the Company's website www.bioservo.com on
Proposed agenda
- Opening of the Meeting
- Appointment of chairman of the Meeting
- Preparation and approval of the voting list
- Approval of the agenda
- Election of one or two persons to approve the minute
- Determination that the Meeting has been duly convened
- Submission of the annual accounts and the auditor
-
Resolution regarding:
a) the adoption of the income statement and the balance sheet
b) appropriation of the Company's results in accordance with the adopted balance sheet
c) discharge of the members of the board of directors and the managing director from liability - Determination of fees for members of the board of directors and auditors
- Election of members of board of directors and election of auditor
- Resolution on amendments to the articles of association
- Resolution on an issue authorisation
- Closing of the Meeting
Proposed for decision
Election of chairman of the meeting (item 2)
Fees to the Board and auditors (item 9)
The Board of Directors proposes that unchanged annual fees be paid to the Board of Directors of
Election of members of board of directors and election of auditor (item 10)
The Nomination Committee proposes re-election of the Board members
The nomination committee proposes
Resolution on amendments to the articles of association (item 11)
The Board of Directors proposes that the general meeting resolves on amendments to the articles of association mainly in according to the following.
The Board of Directors proposes that the articles of association are amended in such way that the limit to the number of shares in the Company is increased from a minimum of 18,000,000 shares and a maximum of 72,000,000 shares to a minimum of 28,000,000 shares and a maximum of 112,000,000 shares and that the limit to the share capital in the Company is increased from a minimum of
In addition to the above proposals, the board of directors also proposes certain editorial changes to the articles of association.
Resolution on an issue authorisation (item 12)
The Board of Directors proposes that the general meeting resolves on an issue authorisation according to the following.
The Board of Directors is to be authorised to, on one or more occasions until the next annual general meeting, resolve on issue of new shares, issue of convertibles, issue of warrants and/or a combination of these, so called units. An issue can be decided with or without regard of shareholders' pre-emption rights.
This authorisation is to include the right to issue shares, convertibles, warrants and/or units, with cash payment, payment by way of set-off or payment by contribution in kind, and otherwise subject to conditions as set out in Chapter 2, section 5, second paragraph 1-3 and 5 of the Swedish Companies Act. Warrants may be issued without consideration.
The Board of Directors, or its nominee, is entitled to decide on any minor changes in the resolution of the general meeting that may be required when registering the decision with the Swedish Companies Registration Office,
Majority requirements
A valid resolution in accordance with items 11 and 12 requires that the resolutions be supported by shareholders with at least two thirds of both the votes and the shares represented at the meeting.
Documents
The complete documents in accordance with the Swedish Companies Act will be available at the company and on the company's website and will be sent immediately without charge to any shareholders who so request and has states their address. The documents will also be available at the meeting.
Information at the meeting
The Board of Directors and the CEO shall, upon request by any shareholder, and where the Board deems that the information can be provided without significant harm to the company, provide information at the meeting on matters that may affect the assessment of an item on the agenda, circumstances that may influence determination of the financial position of the Company, the consolidated accounts and the Company's relationship to another group company.
Processing of personal data
For information on how your personal data is processed, please see
https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.
_________________
Kista in
The Board of Directors
https://news.cision.com/bioservo-technologies-ab--publ-/r/notice-to-annual-general-meeting-in-bioservo-technologies-ab--publ-,c3739795
https://mb.cision.com/Main/15771/3739795/1938044.pdf
(c) 2023 Cision. All rights reserved., source